Ilse Wallaard

contact

  • i.wallaard@erasmusmc.nl
  • +31 010 70 37739
  • Room: Ee-1438
  • Dr. Molewaterplein 40, Faculty Building, Rotterdam, The Netherlands

Ilse Wallaard (I.)

Publications

1. A recurrent missense variant in the E3 ubiquitin ligase substrate recognition subunit FEM1B causes a rare syndromic neurodevelopmental disorder.

Lecoquierre F, Punt AM, Ebstein F, Wallaard I, Verhagen R, Studencka-Turski M, Duffourd Y, Moutton S, Tran Mau-Them F, Philippe C, Dean J, Tennant S, Brooks AS, van Slegtenhorst MA, Jurgens JA, Barry BJ, Chan WM, England EM, Martinez Ojeda M, Engle EC, Robson CD, Morrow M, Innes AM, Lamont R, Sanderson M, Krüger E, Thauvin C, Distel B, Faivre L, Elgersma Y, Vitobello A
in Genetics in medicine : official journal of the American College of Medical Genetics 2024
DOI: 10.1016/j.gim.2024.101119

2. UBE3A expression during early postnatal brain development is required for proper dorsomedial striatal maturation.

Rotaru DC, Wallaard I, de Vries M, van der Bie J, Elgersma Y
in JCI insight 2023
DOI: 10.1172/jci.insight.166073

3. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder.

Niggl E, Bouman A, Briere LC, Hoogenboezem RM, Wallaard I, Park J, Admard J, Wilke M, Harris-Mostert EDRO, Elgersma M, Bain J, Balasubramanian M, Banka S, Benke PJ, Bertrand M, Blesson AE, Clayton-Smith J, Ellingford JM, Gillentine MA, Goodloe DH, Haack TB, Jain M, Krantz I, Luu SM, McPheron M, Muss CL, Raible SE, Robin NH, Spiller M, Starling S, Sweetser DA, Thiffault I, Vetrini F, Witt D, Woods E, Zhou D, Elgersma Y, van Esbroeck ACM
in American journal of human genetics 2023
DOI: 10.1016/j.ajhg.2023.07.005

4. Adult gene reinstatement restores the learning and plasticity deficits of knockout mice.

Rigter PMF, Wallaard I, Aghadavoud Jolfaei M, Kingma J, Post L, Elgersma M, Elgersma Y, van Woerden GM
in iScience 2022
DOI: 10.1016/j.isci.2022.105303

5. Multidimensional analysis of behavior predicts genotype with high accuracy in a mouse model of Angelman syndrome.

Tanas JK, Kerr DD, Wang L, Rai A, Wallaard I, Elgersma Y, Sidorov MS
in Translational psychiatry 2022
DOI: 10.1038/s41398-022-02206-3

6. Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model.

Milazzo C, Mientjes EJ, Wallaard I, Rasmussen SV, Erichsen KD, Kakunuri T, van der Sman ASE, Kremer T, Miller MT, Hoener MC, Elgersma Y
in JCI insight 2021
DOI: 10.1172/jci.insight.145991

7. Effects of antiepileptic drugs in a new TSC/mTOR-dependent epilepsy mouse model.

Koene LMC, van Grondelle SE, Proietti Onori M, Wallaard I, Kooijman NHRM, van Oort A, Schreiber J, Elgersma Y
in Annals of clinical and translational neurology 2019
DOI: 10.1002/acn3.50829

8. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel mutants.

Sonzogni M, Wallaard I, Santos SS, Kingma J, du Mee D, van Woerden GM, Elgersma Y
in Molecular autism 2018
DOI: 10.1186/s13229-018-0231-7

9. Adult Ube3a Gene Reinstatement Restores the Electrophysiological Deficits of Prefrontal Cortex Layer 5 Neurons in a Mouse Model of Angelman Syndrome

Rotaru DC, van Woerden GM, Wallaard I, Elgersma Y
in J Neurosci 2018
DOI: 10.1523/JNEUROSCI.0083-18.2018
show more publications